Sulfhydryl groups of renal D1A dopamine receptors: Differential sensitivity of receptors to N-ethylmaleimide in normotensive and hypertensive rats

Journal of Hypertension

Volumn 14, Issue 5, 1996, Pages 615-622

  Sela, Shifra ^a   Sidhu, Anita ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antioxidants; Dopamine receptors; Hypertension; Radioligand binding; Spontaneously hypertensive rat

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; N ETHYLMALEIMIDE; THIOL GROUP;

ALKYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL MEMBRANE; CONTROLLED STUDY; HYPERTENSION; KIDNEY PROXIMAL TUBULE; LIGAND BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR OCCUPANCY; RECEPTOR SENSITIVITY;

EID: 0029896412     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199605000-00011     Document Type: Article

References (33)

1. Robles RG, Villa E, Andres A, Martinez J, Ruilope LM, Sancho JM: Natriuretic effects of dopamine agonist drugs In models of reduced renal mass. J Cardiovasc Pharmacol 1993, 22 (suppl 2):88-92.
2. A receptor function as the causative factor for diminished natriuresis to volume expansion in spontaneously hypertensive rats. Clin Exp Hypertens 1992, 14:615-628.
3. +-ATPase activity in spontaneously hypertensive rats. In Genetic Hypertension. Edited by Sassard J. Paris: John Libbey Eurotext Ltd; 1992, 218:463-465.
4. +-ATPase by G proteins in spontaneously hypertensive rats. Am J Physiol 1994, 267:F1069-F1075.
5. +-ATPase in nephron segments of rats developing spontaneous hypertension. Am J Physiol 1985, 249:F863-F869.
6. Shiekhamad D, Jo OD, Yanagawa N, Lee DB: Sodium (Na) transport by isolated renal brush border membrane vesicles (BBMV) from spontaneously hypertensive rats (SHR): increased Na/H countertransport (CT) [abstract]. Kidney Int 1986, 31:309.
7. + antiport activity in the renal brush border membrane of SHR. Kidney Int 1989, 36:576-581.
8. Kinoshita S, Sidhu A, Felder RA: Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubules from the spontaneously hypertensive rat. J Clin Invest 1989, 84:1849-1856.
9. Sidhu A, Vachvanichsanong P, Jose PA, Felder RA: Persistent defective coupling of dopamine-1 receptors to G proteins after solubilization from kidney proximal tubules of hypertensive rats. J Clin Invest 1992, 89:789-793.
10. 1 dopamine receptors in renal proximal tubules from normotensive and SHR. Am J Physiol 1995, 26B:F1009-F1016.
11. 5 protein from spontaneously hypertensive rats. Hypertension 1994, 24:595-596.
12. Fu M, Matoba M, Liang QM, Sjogren KG, Hjalmarson A: Properties of G-protein modulated receptor-adenylyl cylcase system in myocardium of spontaneously hypertensive rats treated with adriamycin. Int J Cardiol 1994, 44:9-18.
13. Dixon RAF, Sigal IS, Candelore MR, et al.: Structural features required for ligand binding to the β-adrenergic receptor. EMBO J 1987, 6:3269-3275.
14. Dohlman HG, Thorner J, Caron MG, Lefkowitz RJ: Model systems for the study of seven-transmembrane-segment receptors. Annu Rev Biochem 1991, 60:653-688.
15. Sidhu A, Kassis S, Kebabian J, Fishman PH: Sulfhydryl group(s) in the ligand binding site of the D-1 dopamine receptor: specific protection by agonist and antagonist. Biochemistry 1986, 25:6695-6701.
16. Sidhu A, Kimura K, Vachvanichsanong P: Induction of G protein-independent agonist high-affinity binding sites of D-1 dopamine receptors by β-mercaptoethanol. Biochemistry 1994, 33:11246-11253.
17. 1 dopamine receptors. J Neurochem 1994, 63:2093-2098.
18. 1 receptors: effects of thiol modifying reagents. Neurosci Abstr 1987, 13:1198.
19. 1 receptors in cerebral cortex and neostriatum: role of disulfide and sulfhydryl groups. J Neurochem 1989, 52:472-482.
20. + transport defect in SHR. Am J Physiol 1992, 263:F1105-F1111.
21. Sidhu A, Sullivan M, Kohout T, Balen P, Fishman PH: D-1 dopamine receptors can interact with both stimulatory and Inhibitory G proteins. J Neurochem 1991, 57:1445-1451.
22. 0. J Biol Chem 1995, 270:14672-14678.
23. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein dye binding. Anal Biochem 1976, 72:248-254.
24. O'Dowd BF: Structures of dopamine receptors. J Neurochem 1993, 60:804-816.
25. Gingrich JA, Caron MG: Recent advances in the molecular biology of dopamine receptors. Annu Rev Neurosci 1993, 16:299-321.
26. Lohkandwala MF, Amenta F: Anatomical distribution and function of dopamine receptors in the kidney. FASEB J 1992, 5:3023-3030.
27. Sagar S, Kallo U, Kaul N, Ganguly NK, Sharma BK: Oxygen free radicals in essential hypertension. Mol Cel Biochem 1992, 111:103-108.
28. Sharma RC, Crawford DW, Kramsch DM, Sevanian A, Jiao Q: Immunolocalization of native antioxidant scavenger enzymes in early hypertensive and atherosclerotic arteries. Arterioscler Thromb 1992, 12:403-415.
29. Bridges AB, Scott NA, Pringle TH, McNeill GP, Belch JJF: Relationship between the extent of coronary artery disease and indicators of free radical activity. Clin Cardiol 1992, 15:169-174.
30. Ceriello A, Giugliano D, Quatraro A, Lefebvre PJ: Anti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. Clin Sci Colch 1991, 81:739-742.
31. Janssen M, de Jong JW, Ferrari R: Myocardial xanthine oxidoreductase activity in hypertensive and hypercholesterolemic rats. Cardioscience 1993, 4:25-29.
32. Lahera V, Khraibi AA, Romero JC: Sulfhydryl group donors potentiate the hypertensive effect of acetylcholine in rats. Hypertension 1993, 22:156-160.
33. Ito H, Torii M, Suzuki T: A comparative study on defense systems for lipid peroxidation by free radicals in spontaneously hypertensive and normotensive myocardium. Comp Biochem Physiol 1992, 103:37-40.